|
New oral anticoagulant therapy for the prevention of blood clots following hip or knee replacement surgery Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or professional assistance by using a genuine doctor. We aren't mDs. Always consult your physician about New oral anticoagulant therapy for the prevention of blood clots following hip or knee replacement surgery conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. New oral anticoagulant therapy for the prevention of blood clots following hip or knee replacement surgery Clinical research trials and New oral anticoagulant therapy for the prevention of blood clots following hip or knee replacement surgery health trials occur in a lot of of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the potency of new does drugs. The role of the studies / undertakings is to figure out specific human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all sorts of conditions, including New oral anticoagulant therapy for the prevention of blood clots following hip or knee replacement surgery. New oral anticoagulant therapy for the prevention of blood clots following hip or knee replacement surgery Clinical Trials and other clinical trials permit volunteers to get medical treatment choices before they are available to the general public. Many times the test subjects get professional assistance for free of charge, and occasionally they are compensated for their time. Sometimes there is a cost for a New oral anticoagulant therapy for the prevention of blood clots following hip or knee replacement surgery clinical trial. Human subjects often get the best healthcare possible for their New oral anticoagulant therapy for the prevention of blood clots following hip or knee replacement surgery condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, medical hazards (perhaps life-threatening), and/or the treatment being ineffectual. Trials are federally governed with exacting guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "N" Clinical Trials Conditions > New oral anticoagulant therapy for the prevention of blood clots following hip or knee replacement surgery  New oral anticoagulant therapy for the prevention of blood clots following hip or knee replacement surgery
New oral anticoagulant therapy for the prevention of blood clots following hip or knee replacement surgery
For Condition: Total Hip Replacement,Total Knee Replacement
Status: Recruiting
Sponsor(s): Eli Lilly and Company ,
Synopsis: LY517717 (a capsule given by mouth) is a blood thinner that may prevent blood clots from forming in the legs and may prevent those blood clots from traveling to the lungs. Leg and lung blood clots occur commonly after pateints have surgery to replace a hip or knee joint. These clots often occur while patients are in bed in the hospital after hip or knee joint surgery. The purpose of this study is to test if different dose strengths (amount of drug in the capsules) of LY517717 can prevent blood clots from forming and to determine if LY517717 is safe. This study will compare LY517717 to enoxaparin, another blood thinner. Enoxaparin is one of the standard medications given after hip or knee joint surgery.
Details:
Eligibility:
Study Type: Interventional, Prevention
Minimum Age/Maximum Age: 18 Years/75 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Are scheduled for total knee or hip replacement surgery (only one side, first time joint replacement) - Are at least 18 years of age and no more than 75 years of age. - Have a body weight more than 50 kg and less than 120 kg. - Sign an approved Eli Lilly and Company informed consent document. Exclusion Criteria: - Have had hip or knee replacement surgery in the non-surgical leg or any surgical procedure in the surgical leg within 6 months prior to enrollment. - Other surgeries (brain, spinal cord, eye within 12 months; chest or abdominal surgery within 1 month). - Have taken drugs that might increase possibility of bleeding. - Other risk factors for bleeding (bleeding disorders, abnormal results on blood tests, ulcers) - Increased risk for blood clots.
Total Enrollment:
Location and Contact Information:
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician." *Recruiting*
Pavia, ,
Italy
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician." *Recruiting*
Brno, ,
Czech Republic
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. *Recruiting*
Perugia, ,
Italy
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician." *Recruiting*
Bydgoszcz, ,
Poland
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician." *Recruiting*
Gubbio, ,
Italy
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician." *Recruiting*
Reggio Emilia, ,
Italy
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician." *Recruiting*
Plzen, ,
Czech Republic
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician." *Recruiting*
Aachen, ,
Germany
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician." *Recruiting*
Pardubice, ,
Czech Republic
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician." *Recruiting*
Brussels, ,
Belgium
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician." *Recruiting*
Ostrava-Poruba, ,
Czech Republic
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician." *Recruiting*
Slaskie, ,
Poland
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician." *Recruiting*
Vienna, ,
Austria
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician." *Recruiting*
Olomouc, ,
Czech Republic
Recruiting
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician." *Recruiting*
Torino, ,
Italy
Recruiting
Additional Information:
Study ID Numbers: 8113;
Study Start Date:
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00074828
Other Total Hip Replacement Studies:
1. New oral anticoagulant therapy for the prevention of blood clots following hip or knee replacement surgery
Related Studies:
Other Total Hip Replacement Clinical Trials
Other Clinical Trials
Other Ostrava-Poruba Clinical Trials
New oral anticoagulant therapy for the prevention of blood clots following hip or knee replacement surgery
|
|
|
|
|
|
|
|
